Sep 2026· International Journal of Women's Health· Vol 18· 0 citations· 30 references
Medicine
TL;DR
Findings reveal persistent global growth in endometriosis incidence coupled with stark interregional disparities, which warrants further investigation, particularly given Oceania’s disproportionately high burden despite its advanced SDI status.
Abstract
Purpose This study utilized 1990–2019 data from the Global Burden of Disease (GBD) 2019 study to comprehensively evaluate global and regional temporal trends of endometriosis burden. Patients and Methods Age-standardized incidence rates (ASIR) and disability-adjusted life year (DALY) rates were extracted from GBD 2019. Using the DisMod-MR 2.1 modeling framework, we analyzed three-decade trends across 204 countries and territories. Results Globally, endometriosis presented opposing trends in age-standardized incidence rate (ASIR) and age-standardized DALY rate from 1990 to 2019. The global age-standardized DALY rate declined markedly, with an EAPC of −0.82, while the ASIR rose steadily (EAPC = 0.46). Stratified by Socio-Demographic Index (SDI), high-SDI regions witnessed the most prominent growth in ASIR, with an EAPC of 0.54. Among the 21 GBD geographic regions, High-income North America had the fastest ASIR growth (EAPC = 0.65). Eastern Europe was the only region with rising age-standardized DALY rates (EAPC = 0.16). Oceania bore the world’s largest overall endometriosis burden, with the highest ASIR and age-standardized DALY rates globally. At the national level, New Zealand had the highest disease burden, whereas San Marino and Sweden showed the steepest increases in incidence rates. Conclusion These findings reveal persistent global growth in endometriosis incidence coupled with stark interregional disparities. The paradox of rising incidence alongside declining disability warrants further investigation, particularly given Oceania’s disproportionately high burden despite its advanced SDI status.
From 1990 to 2021, global incidence, mortality, and DALYs attributable to OC increased, particularly in regions with lower Socio-demographic Index levels, while high-SDI regions showed relatively stable or declining mortality.
Jian-Qiang Xin, Wei-Ling Chen, Dong-Zhen Li et al.· Medicine· 0 citations
Ovarian cancer is one of the most lethal gynecological malignancies globally, with significant variations in incidence, prevalence, and outcomes across regions and population subgroups. This study systematically evaluates the global, regional, and national burden of ovarian cancer from 1990 to 2021, utilizing data from...
Despite global progress, marked inequalities persist, and forecasts indicate continued prevalence rise and substantial mortality reduction by 2031, with persistent inequalities.
Mei Zhao, Chunmei Qiu, Li-ping Cai et al.· Journal of Maternal-Fetal &...· 0 citations
Despite substantial declines in age-standardized mortality and DALY rates, absolute CRC burden in G20 countries has increased dramatically over three decades, driven by population growth and aging.
Ke Zhang, Zhi-Fei Chen· Digestive Diseases· 0 citations
This study aims to systematically compare the epidemiological patterns and long-term trends of pancreatitis burden between China and the United States.
Using the Global Burden of Disease (GBD) 1990–2023 data, we analyzed the burden of pancreatitis in China and the United States, including prevalence, incid...